SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-14-000073
Filing Date
2014-08-19
Accepted
2014-08-19 16:02:53
Documents
11
Period of Report
2014-08-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201408198xkdoc.htm 8-K 29498
2 PRESENTATION pdli-201408198xkex991.htm EX-99.1 3899
3 INFORMATION SHEET pdli-201408198xkex992.htm EX-99.2 537492
4 slide1a06.jpg GRAPHIC 130274
5 slide2a06.jpg GRAPHIC 221497
6 slide3a06.jpg GRAPHIC 124892
7 slide4a06.jpg GRAPHIC 118697
8 slide5a06.jpg GRAPHIC 90444
9 slide6a06.jpg GRAPHIC 158546
10 slide7a06.jpg GRAPHIC 111317
11 slide8a06.jpg GRAPHIC 116106
  Complete submission text file 0000882104-14-000073.txt   2049716
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 141052110
SIC: 2836 Biological Products, (No Diagnostic Substances)